NEW DELHI (Reuters) - The European Union's ban on Indian generic drugs is "unwarranted" and an obstacle to moving trade talks forward, India's foreign secretary said on Monday.
Subrahmanyam Jaishankar said EU restrictions on more than 700 generic drugs were unfair.
"It's our hope that this matter would be looked at fairly and sensibly and would hopefully not be an impediment to the free trade deal," he told journalists after German Chancellor Angela Merkel met with Prime Minister Narendra Modi during a visit to New Delhi.
India and Germany pledged on Monday to revive efforts to reach an Indo-European free trade pact after talks fell apart this year.
(Reporting by Douglas Busvine; Writing by Tommy Wilkes)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app